MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3

Oncotarget

Volumn 6, Issue 38, 2015, Pages 40799-40814

  Teng, Yue ^a   Zhang, Yan ^a   Qu, Kai ^a   Yang, Xinyuan ^a   Fu, Jing ^a   Chen, Wei ^a   Li, Xu ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

AKT; Epithelial ovarian cancer; MicroRNA; MiR 29b; Warburg effect

Indexed keywords

GLUCOSE; LACTIC ACID; MICRORNA 29B; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN AKT3; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN KINASE B INHIBITOR; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AKT2 PROTEIN, HUMAN; AKT3 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN29 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CARCINOMA CELL LINE; CELL PROLIFERATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLYCOLYSIS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; WARBURG EFFECT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BAGG ALBINO MOUSE; DRUG SCREENING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOLYSIS; HUMANS; IMMUNOENZYME TECHNIQUES; LACTIC ACID; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84951168547     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5695     Document Type: Article

References (48)

1. Warburg O. On the origin of cancer cells. Science. 1956; 123:309-314.
2. Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol. 2009; 19:17-24.
3. Robey RB, Hayd N. Is AKT the "Warburg kinase"?-AKTenergy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009; 19:25.
4. VanderHeiden MG, Cantley LC, Thomson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324:1029-1033.
5. Young CD, Nolte EC, Lewis A, Serkova NJ, Anderson SM. Activated AKT1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3. Breast Cancer Res. 2008; 10:R70.
6. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007; 23:175-205.
7. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466:835-840.
8. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates selfrenewal and tumorigenicity of breast cancer cells. Cell. 2007; 131:1109-1123.
9. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009; 458:762-765.
10. Rayner KJ, Sua'rez Y, Da'valos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Ferna'ndez-Hernando C. miR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010; 328:1570-1573.
11. Eskander RN, Tewari KS. Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer. Clin Pharmacol. 2013; 5:S55-61.
12. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009; 114:5331-5341.
13. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011; 412:74-79.
14. Xu F, Zhang Q, Cheng W, Zhang Z, Wang J, Ge J. Effect of miR-29b-1 and miR-29c knockdown on cell growth of the bladder cancer cell line T24. J Int Med Res. 2013; 41:1803-1810.
15. Poudyal D, Cui X, Le PM, Hofseth AB, Windust A, Nagarkatti M, Nagarkatti PS, Schetter AJ, Harris CC, Hofseth LJ. A key role of microRNA-29b for the suppression of colon cancer cell migration by American ginseng. PLoS One. 2013; 8:e75034.
16. Flavin R, Smyth P, Barrett C, Russell S, Wen H, Wei J, Laios A, O'Toole S, Ring M, Denning K, Li J, Aherne S, Sammarae D. etc. miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma. Int J Gynecol Cancer. 2009; 19:641-647.
17. Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. Eur J Cell Biol. 2013; 92:123-128.
18. Mersey BD, Jin P, Danner DJ. Human microRNA (miR29b) expression controls the amount of branched chain alphaketoacid dehydrogenase complex in a cell. Hum Mol Genet. 2005; 14:3371-3377.
19. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic beta-cell specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol. 2011; 31:3182-3194.
20. Joo NS, Kim KN, Kim KS. Serum CA125 concentration has inverse correlation with metabolic syndrome. J Korean Med Sci. 2011; 26:1328-1832.
21. Esteghamati A, Seyedahmadinejad S, Zandieh A, Esteghamati A, Gharedaghi MH, Sadaghiani MS, Saadipoor A, Nakhjavani M. The inverse relation of CA-125 to diabetes, metabolic syndrome, and associated clinical variables. Metab Syndr Relat Disord. 2013; 11:256-261.
22. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009; 23:537-548.
23. Nakashima RA, Paggi MG, Scott LJ, Pedersen PL. Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res. 1988; 48:913-919.
24. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452:230-233.
25. Nie S, Li K, Huang Y, Hu Q, Gao X, Jie S. miR-495 mediates metabolic shift in glioma cells via targeting Glut1. J Craniofac Surg. 2015; 26:e155-158.
26. Cui J, Shi M, Xie D, Wei D, Jia Z, Zheng S, Gao Y, Huang S, Xie K. FOXM1 promotes the Warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res. 2014; 20:2595-2606.
27. Gonzalez E, McGraw TE. Insulin-modulated AKT subcellular localization determines AKT isoform-specific signaling. Proc Natl Acad Sci U S A. 2009; 106:7004-7009.
28. Walter BA, Valera VA, Pinto PA, Merino MJ. Comprehensive microRNA Profiling of Prostate Cancer. J Cancer. 2013; 4:350-357.
29. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002; 277:7610-7618.
30. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001; 15:1406-1418.
31. Bustamante E, Pedersen PL. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA. 1977; 74:3735-3739.
32. Keun JA, Hee SH, Jeon HP, Seong HB, Won JK, Mijin Yun, Jong DL. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines. J Nucl Med. 2009; 50:1525-1532.
33. Ivan Nemazanyy, Catherine Espeillac, Mario Pende1 and Ganna Panasyuk. Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression. Biochem Soc Trans. 2013; 41:917-922.
34. Mersey BD, Jin P, Danner DJ. Human microRNA (miR29b) expression controls the amount of branched chain alphaketoacid dehydrogenase complex in a cell. Hum Mol Genet. 2005; 14:3371-3377.
35. Mott JL, Kobayashi S, Bronk SF, Gores GJ. miR-29 regulates Mcl-1 protein expression and apoptosis. Oncogene. 2007; 26:6133-6140.
36. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009; 114:5331-5341.
37. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology. 2010; 51:836-845.
38. Steele R, Mott JL, Ray RB. MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer. 2010; 1:381-387.
39. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008; 13:472-482.
40. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2008; 324:1029-1033.
41. Orom UA, Kauppinen S, Lund AH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene. 2006; 372:137-141.
42. Kosugi M1, Ahmad R, Alam M, Uchida Y, Kufe D. MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells. PLoS One. 2011; 6:e28234.
43. Zhang BL, Feng SP, Cong SJ, Zhang X, Bao XC, Wang W, Li HP, Wang Z, Wang GX, Xu JZ, Du BW, Qu DZ, Xiong W. etc. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res. 2011; 39:6669-6678.
44. Wang J, Ma Y, Jiang H, Zhu H, Liu L, Sun B, Pan S, Krissansen GW, Sun X. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice. J Hepatol. 2011; 55:359-368.
45. Huang B, Lei Z, Zhang GM, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H, Feng ZH. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008; 112:1269-1279.
46. Kang F, Ma WH, Ma XW, Shao YH, Yang WD, Chen XY, Li LW, Wang J. Propranolol Inhibits Glucose Metabolism and 18F-FDG Uptake of Breast Cancer Through Posttranscriptional Downregulation of Hexokinase-2. J Nucl Med. 2014; 55:439-445.
47. Xie QG, Chen YB, Zhu J, Liu JJ, Wang X, Liu W, Chen X, Niu M, Wu ZY, Xi DM, Wang LY, Xiao P, Chen CT, Kao CM. Implementation of LYSO/PSPMT block detector with all digital DAQ system. IEEE transactions on nuclear science. 2013; 60:1487-1494.
48. Yan GR, Tian J, Zhu SP, Dai YK, Qin CH. Fast conebeam CT image reconstruction using GPU hardware. Journal of X-Ray Science and Technology. 2008; 16:225-234.